Skip to main content

Table 1 Clinicopathological data of the included patients

From: St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial

Characteristics

Number of patients (%)

All patients

 

85 (100)

Age

Median (range)

64 (26–76)

HER2

Positive

17 (20)

 

Negative

68 (80)

Ki67

≤ 20%

54 (74)

 

> 20%

19 (26)

ER status

Positive

62 (73)

 

Negative

23 (27)

Pr status

Positive

41 (48)

 

Negative

44 (52)

Histology

Ductal

67 (81)

 

Lobular

10 (12)

 

Ductal + Lobular

4 (5)

 

Other

2 (2)

 

Missing

2

Tumor size

≤ 20%

25 (29)

 

> 20%

60 (71)

Grade

1

2 (3)

 

2

36 (60)

 

3

22 (37)

 

Missing

25

Nodal status

N1

22 (26)

 

N2-3

25 (29)

 

N4+

38 (45)

Events1

Yes

25 (29)

 

No

60 (71)

  1. Abbreviations: ER oestrogen receptor, PR progesteron receptor, HER2 human epidermal growth factor receptor 2, Grade Nottingham histological grade.
  2. 1Events: recurrence and/or death in breast cancer disease.